A 71-year-old female patient underwent cataract surgery in the left eye on (b)(6) 2023 where the micor lens fragmentation system (extractor and drive) was used to remove the cataractous lens fragments.During the micor procedure there was anterior chamber fluctuation and the posterior capsule tore which resulted in vitreous fluid loss.A vitrectomy was performed and a 3-piece intraocular lens was implanted in the sulcus.Preoperatively, the patient's best corrected visual acuity (bcva) was 20/25.Postoperatively, the patient's bcva improved to 20/20 and the patient was reported as doing well.
|
The micor extractor was returned to the manufacturer and evaluated.The device was subjected to visual inspection, functional testing, then disassembled for internal inspection.There was no damage or device malfunction identified and the device met specifications and performed as intended.The published literature was reviewed for comparison of the functional test results for forced occlusion response; the investigation data shows the device operates within the same expected ranges for similar marketed phacoemulsification devices.The micor extractor device history records were reviewed for this manufacturing lot and there were no discrepancies or unusual findings that relate to the reported event.Based on the information reviewed, there is no evidence to indicate the presence of a potential quality issue with respect to manufacturing, design, or labeling.The device labeling identifies capsular rupture as an inherent safety risk.Manufacturer's reference #:(b)(4).
|